Peter Sandercock And Ist-3
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:12:54
- Mais informações
Informações:
Sinopse
Acute ischemic stroke is a major public health burden and globally a common cause of death and disability
Episódios
-
Peter Sandercock and IST-3
17/08/2010 Duração: 12minAcute ischemic stroke is a major public health burden and globally a common cause of death and disability. Intravenous recombinant tissue plasminogen activator (rt-PA) is approved for use in selected patients with ischemic stroke within 3 hours of symptom onset. The International Stroke Trial or IST-3 seeks to determine whether a wider range of patients may benefit the International Journal of Stroke spoke to chief investigator Dr Peter Sandercock.